Ribi, Karin http://orcid.org/0000-0003-4724-1197
Pagan, Eleonora
Sala, Isabella
Ruggeri, Monica
Bianco, Nadia
Bucci, Eraldo Oreste
Graffeo, Rossella
Borner, Markus
Giordano, Monica
Gianni, Lorenzo
Rabaglio, Manuela
Freschi, Andrea
Cretella, Elisabetta
Seles, Elena
Farolfi, Alberto
Simoncini, Edda
Ciccarese, Mariangela
Rauch, Daniel
Favaretto, Adolfo
Glaus, Agnes
Berardi, Rossana
Franzetti-Pellanda, Alessandra
Bagnardi, Vincenzo
Gelber, Shari
Partridge, Ann H.
Goldhirsch, Aron
Pagani, Olivia
Funding for this research was provided by:
Frontier Science &Technology Research Foundation
International Breast Cancer Study Group
Article History
Received: 16 February 2022
Accepted: 26 May 2022
First Online: 10 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The manuscript does not contain any individual person’s data in any form, and consent for publication was therefore not obtained from the patients included in this study.
: Karin Ribi reports no conflicts related to this study, Eleonora Pagan reports no conflicts related to this study, Isabella Sala reports no conflicts related to this study, Monica Ruggeri reports no conflicts related to this study, Nadia Bianco reports no conflicts related to this study, Eraldo Oreste Bucci receives consulting or advisory fees from Astra Zeneca and travels/accommodations from Astellas, BMS, Lilly, Merck Serono, Roche, Takeda, Rossella Graffeo reports no conflicts related to this study, Markus Borner reports no conflicts related to this study, Monica Giordano reports no conflicts related to this study, Lorenzo Gianni receives consulting or advisory fees from Astra Zeneca and travels/accommodations from Novartis, Manuela Rabaglio reports no conflicts related to this study, Andrea Freschi reports no conflicts related to this study, Elisabetta Cretella reports no conflicts related to this study, Elena Seles reports no conflicts related to this study, Alberto Farolfi receives honoraria from Janssen Oncology, GSK-Tesaro, Astrazeneca, Clovis, Edda Simoncini reports no conflicts related to this study, Mariangela Ciccarese reports no conflicts related to this study, Daniel Rauch (<i>pending</i>), Adolfo Favaretto reports no conflicts related to this study, Agnes Glaus reports no conflicts related to this study, Rossana Berardi receives donations to her institution and/or fees for advisory board participations from AZ, BI, Novartis, MSD, Otsuka, Lilly, Roche, Amgen, GSK, EISAI (none related to this study), Alessandra Franzetti-Pellanda reports no conflicts related to this study, Vincenzo Bagnardi reports no conflicts related to this study, Shari Gelber reports no conflicts related to this study, Ann H. Partridge (<i>pending</i>), and Olivia Pagani reports no conflicts related to this study.